1 / 5

That's right!

Correct answer: True

That’s right. Only 20% of eligible US adults aged 45-49 have reported screening for CRC.1 Epic Research, which utilizes electronic health records data, has shown that eligible patients in this age group prefer a noninvasive stool-based option like the Cologuard® test, as the use of these tests has increased 9x since the ACS updated its guidelines in 2018.2

Sorry, that’s incorrect.

Correct answer: True

Sorry, that’s incorrect. Only 20% of eligible US adults aged 45-49 have reported screening for CRC, which is the same age group that is seeing an increase in CRC incidence.1 This group has also been shown to prefer a noninvasive stool-based test, like the Cologuard® test. Epic Research, which utilizes electronic health records data, has shown that use of these tests has increased 9x in adults 45-49 since the ACS updated its guidelines in 2018.2

References and footnotes

  • 1.American Cancer Society. Colorectal Cancer Facts & Figures 2023-2025. Atlanta: American Cancer Society; 2023.
  • 2.Bartelt K, Piff A, Allen S, Trinkl J, Barkley E, Stamp T. DNA stool tests for colorectal cancer screening growing in popularity, especially for patients under age 50. Updated May 14, 2014. Accessed October 14, 2024.